[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/27/2017 – 03/03/2017:

1) XTNT – Xtant Medical Holdings Inc – Trading Below Cash
a. Buy at < ~ $0.31
b. Sell at >~ $0.84
c. Catalysts:
1. The company expects to launch four to six new products in 2017 to help drive revenue growth in 2018 and beyond; 20170131; 20171231; http://seekingalpha.com/instablog/44479986-leny-hettmansperger/4952733-xtnt-34c-ceo-resigns-leaving-behind-stronger-company-significant-upside-potential
2. Q4 2016 Xtant Medical Holdings Inc Earnings Release (Estimated)
-; 20170313; 20170313; https://www.google.com/finance?q=XTNT

2) TRVN – Trevena Inc
a. Buy at < ~ $3.70
b. Sell at >~ $8.00
c. Catalysts:
1. Q4 2016 Trevena Inc Earnings Release (Estimated)
-; 20170307; 20170307; https://www.google.com/finance?q=TRVN

3) NVET – Nexvet Biopharma plc
a. Buy at < ~ $2.66
b. Sell at >~ $5.70

4) MICT – Micronet Enertec Technologies Inc
a. Buy at < ~ $1.14
b. Sell at >~ $1.58

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/27/2017 - 03/03/2017, and Why?

[Michael DeVries]

In a big win for rural delivery, UPS just tested a delivery
drone => https://www.bloomberg.com/news/articles/2017-02-21/ups-tries-arming-its-brown-clad-drivers-with-an-octocopter-drone

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/20/2017 – 02/24/2017:

1) XTNT – Xtant Medical Holdings Inc – Trading Below Cash
a. Buy at < ~ $0.31
b. Sell at >~ $0.84
c. Catalysts:
1. The company expects to launch four to six new products in 2017 to help drive revenue growth in 2018 and beyond; 20170131; 20171231; http://seekingalpha.com/instablog/44479986-leny-hettmansperger/4952733-xtnt-34c-ceo-resigns-leaving-behind-stronger-company-significant-upside-potential
2. Q4 2016 Xtant Medical Holdings Inc Earnings Release (Estimated)
-; 20170313; 20170313; https://www.google.com/finance?q=XTNT

2) NVET – Nexvet Biopharma plc
a. Buy at < ~ $2.66
b. Sell at >~ $5.70

3) MICT – Micronet Enertec Technologies Inc
a. Buy at < ~ $1.14
b. Sell at >~ $2.40

4) HSON – Hudson Global Inc – Trading Below Cash
a. Buy at < ~ $1.20
b. Sell at >~ $1.54
c. Catalysts:
1. Q4 2016 Hudson Global Inc Earnings Release (Estimated); 20170301; 20170301; https://www.google.com/finance?q=HSON

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/20/2017 - 02/24/2017, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/13/2017 – 02/17/2017:

1) XTNT – Xtant Medical Holdings Inc – Trading Below Cash
a. Buy at < ~ $0.31
b. Sell at >~ $0.84
c. Catalysts:
1. The company expects to launch four to six new products in 2017 to help drive revenue growth in 2018 and beyond; 20170131; 20171231; http://seekingalpha.com/instablog/44479986-leny-hettmansperger/4952733-xtnt-34c-ceo-resigns-leaving-behind-stronger-company-significant-upside-potential
2. Q4 2016 Xtant Medical Holdings Inc Earnings Release (Estimated)
-; 20170313; 20170313; https://www.google.com/finance?q=XTNT

2) NVET – Nexvet Biopharma plc
a. Buy at < ~ $2.66
b. Sell at >~ $5.70
c. Catalysts:
1. Q2 2017 Nexvet Biopharma plc Earnings Release (Estimated); 20170214; 20170214; https://www.google.com/finance?q=NVET

3) AGLE – Aeglea Bio Therapeutics Inc
a. Buy at < ~ $3.89
b. Sell at >~ $8.20
c. Catalysts:
1. Phase 1 to initiated 1H 2016. Top-line data due 1H2017 – AEB1102 – Arginase I deficiency – Phase 1; 20170101; 20170630; http://services.corporate-ir.net/SEC.Enhanced/SecCapsule.aspx?c=254096&fid=14657424
2. Aeglea BioTherapeutics To Present New Data At 2017 ACMG Annual Clinical Genetics Meeting; 20170321; 20170325; https://www.thestreet.com/story/13956618/1/aeglea-biotherapeutics-to-present-new-data-at-2017-acmg-annual-clinical-genetics-meeting.html

4) MICT – Micronet Enertec Technologies Inc
a. Buy at < ~ $1.14
b. Sell at >~ $2.40

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/13/2017 - 02/17/2017, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/06/2017 – 02/10/2017:

1) XTNT – Xtant Medical Holdings Inc – Trading Below Cash
a. Buy at <~ $0.31
b. Sell at >~ $0.84
c. Catalysts:
1. The company expects to launch four to six new products in 2017 to help drive revenue growth in 2018 and beyond; 20170131; 20171231; http://seekingalpha.com/instablog/44479986-leny-hettmansperger/4952733-xtnt-34c-ceo-resigns-leaving-behind-stronger-company-significant-upside-potential
2. Q4 2016 Xtant Medical Holdings Inc Earnings Release (Estimated)
-; 20170313; 20170313; https://www.google.com/finance?q=XTNT

2) AGLE – Aeglea Bio Therapeutics Inc
a. Buy at <~ $3.89
b. Sell at >~ $8.20
c. Catalysts:
1. Phase 1 to initiated 1H 2016. Top-line data due 1H2017 – AEB1102 – Arginase I deficiency – Phase 1; 20170101; 20170630; http://services.corporate-ir.net/SEC.Enhanced/SecCapsule.aspx?c=254096&fid=14657424
2. Aeglea BioTherapeutics To Present New Data At 2017 ACMG Annual Clinical Genetics Meeting; 20170321; 20170325; https://www.thestreet.com/story/13956618/1/aeglea-biotherapeutics-to-present-new-data-at-2017-acmg-annual-clinical-genetics-meeting.html

3) MICT – Micronet Enertec Technologies Inc
a. Buy at <~ $1.14
b. Sell at >~ $2.40

4) ONCS – OncoSec Medical Inc
a. Buy at <~ $1.20
b. Sell at >~ $2.10
c. Catalysts:
1. Immune monitoring data at ASCO-SITC, Feb 23; 20170223; 20170223; http://immunosym.org/
2. Q2 2017 OncoSec Medical Inc Earnings Release (Estimated)
-; 20170306; 20170306; https://www.google.com/finance?q=ONCS

5) AVIR – Aviragen Therapeutics Inc – Trading Below Cash
a. Buy at <~ $1.14
b. Sell at >~ $2.00
c. Catalysts:
1. Phase 2b top-line data due early February 2017. – Vapendavir – SPIRITUS trial – Human rhinovirus ( – Phase 2b; 20170201; 20170214; http://investors.aviragentherapeutics.com/releasedetail.cfm?ReleaseID=997545

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/06/2017 – 02/10/2017, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 01/23/2017 – 01/27/2017:

1) ROKA – Roka Bioscience Inc – Trading Below Cash
a. Buy at < ~ $3.66
b. Sell at >~ $14.40
c. Catalysts:
1. Q4 2016 Roka Bioscience Inc Earnings Release (Estimated)
-; 20170302; 20170302; https://www.google.com/finance?q=ROKA

2) FLKS – Flex Pharma Inc
a. Buy at < ~ $4.41
b. Sell at >~ $12.00
c. Catalysts:
1. Q4 2016 Flex Pharma Inc Earnings Release (Estimated)
-; 20170306; 20170306; https://www.google.com/finance?q=FLKS
2. Phase 2 initiated June 2016. Readout due 2H2017. – FLX-787 – Multiple Sclerosis – Phase 2; 20171231; 20171231; http://ir.flex-pharma.com/phoenix.zhtml?c=253862&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExMjgwNTY0JkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3
3. Phase 2 initiated September 2016. Readout due 2017/18. – FLX-787 – Amyotrophic lateral sclerosis ( – Phase 2; 20180630; 20180630; http://ir.flex-pharma.com/phoenix.zhtml?c=253862&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExMjgwNTY0JkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3

3) ATNM – Actinium Pharmaceuticals Inc
a. Buy at < ~ $0.86
b. Sell at >~ $2.15
c. Catalysts:
1. Phase 2 initiated September 2016. Interim analysis due mid-2017. – Actimab-A – Acute Myeloid Leukemia ( – Phase 2; 20170731; 20170731; http://ir.actiniumpharma.com/press-releases/detail/203
2. Phase 3 initiated June 2016. Data due 1H2018. – Iomab-B – Hematopoietic Stem Cells Transplantation – Phase 3; 20180630; 20180630; http://ir.actiniumpharma.com/press-releases/detail/203

4) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.17
b. Sell at >~ $2.45
c. Catalysts:
1. Q4 2016 Top Image Systems Ltd Earnings Release (Estimated)
-; 20170306; 20170306; https://www.google.com/finance?q=TISA

5) ARQL – ArQule, Inc.
a. Buy at < ~ $1.20
b. Sell at >~ $2.10
c. Catalysts:
1. Q4 2016 ArQule Inc Earnings Release (Estimated)
-; 20170227; 20170227; https://www.google.com/finance?q=ARQL
2. Phase 3 – Tivantinib (ARQ 197) METIV-HCC trial – Previously treated Inoperable Hepatocellular Carcinoma cancer – Phase 3; 20170331; 20170331; http://investors.arqule.com/releasedetail.cfm?ReleaseID=997914

6) AVIR – Aviragen Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $1.14
b. Sell at >~ $2.00
c. Catalysts:
1. Q2 2017 Aviragen Therapeutics Inc Earnings Release (Estimated)
-; 20170203; 20170203; https://www.google.com/finance?q=AVIR
2. Phase 2b top-line data due early February 2017. – Vapendavir – SPIRITUS trial – Human rhinovirus ( – Phase 2b; 20170214; 20170214; http://investors.aviragentherapeutics.com/releasedetail.cfm?ReleaseID=997545

7) NVLS – Nivalis Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $2.00
b. Sell at >~ $3.00
c. Catalysts:
1. N91115 Cystic Fibrosis – one copy of the F508del mutation and a second mutation that results in a gating defect in the CFTR protein Phase 2
Phase 2 data due 1Q 2017.; 20170101; 20170330; http://biopharmcatalyst.com/companies/company-pipeline-database#sort=company
2. Q4 2016 Nivalis Therapeutics Inc Earnings Release (Estimated); 20170227; 20170227; https://www.google.com/finance?q=NVLS

8) VSTM – Verastem Inc – Trading Below Cash
a. Buy at < ~ $1.07
b. Sell at >~ $1.50
c. Catalysts:
1. Phase 3 data due 1H2017. – Duvelisib – DUO – Cancer – relapsed/refractory chronic lymphocytic leukemia ( – Phase 3; 20170101; 20170630; http://phoenix.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-newsArticle&ID=2218385
2. Q4 2016 Verastem Inc Earnings Release (Estimated); 20170301; 20170301; https://www.google.com/finance?q=VSTM

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 01/23/2017 - 01/27/2017, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 01/09/2017 – 01/13/2017:

1) RXII – RXi Pharmaceuticals Corp
a. Buy at < ~ $0.70
b. Sell at >~ $2.90
c. Catalysts:
1. Phase 2 first cohort data due 2Q 2017. Full data due 2H 2017. – Samcyprone – RXI-SCP-1502 – Cutaneous warts – Phase 2; 20170630; 20170630; http://investors.rxipharma.com/file/Index?KeyFile=37076476
2. Phase 2 final readout due mid 2017. – RXI-109-1402 – Connective tissue growth factor ( – Phase 2; 20170731; 20170731; http://investors.rxipharma.com/file/Index?KeyFile=37076476
3. Phase 2 enrollment to be completed early 2017. Safety data readout due 2H 2017. – RXI-109-1501 – Retinal scarring – Phase 1/2; 20171231; 20171231; http://investors.rxipharma.com/file/Index?KeyFile=37076476

2) ROKA – Roka Bioscience Inc – Trading Below Cash
a. Buy at < ~ $3.66
b. Sell at >~ $14.40
c. Catalysts:
1. Q4 2016 Roka Bioscience Inc Earnings Release (Estimated)
-; 20170302; 20170302; https://www.google.com/finance?q=ROKA

3) ATNM – Actinium Pharmaceuticals Inc
a. Buy at < ~ $0.86
b. Sell at >~ $2.15
c. Catalysts:
1. Phase 2 initiated September 2016. Interim analysis due mid-2017. – Actimab-A – Acute Myeloid Leukemia ( – Phase 2; 20170731; 20170731; http://ir.actiniumpharma.com/press-releases/detail/203
2. Phase 3 initiated June 2016. Data due 1H 2018. – Iomab-B – Hematopoietic Stem Cells Transplantation – Phase 3; 20180630; 20180630; http://ir.actiniumpharma.com/press-releases/detail/203

4) RLJE – RLJ Entertainment Inc
a. Buy at < ~ $1.28
b. Sell at >~ $2.80

5) PDLI – PDL BioPharma Inc
a. Buy at < ~ $1.93
b. Sell at >~ $3.90
c. Catalysts:
1. PDL BioPharma to Present at the 2016 BIO CEO & Investor Conference; 20160209; ;
2. Q4 2016 PDL BioPharma Inc Earnings Release (Estimated)
-; 20170220; 20170220; https://www.google.com/finance?q=PDLI

6) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.17
b. Sell at >~ $2.45
c. Catalysts:
1. Q4 2016 Top Image Systems Ltd Earnings Release (Estimated)
-; 20170306; 20170306; https://www.google.com/finance?q=TISA

7) ARQL – ArQule, Inc.
a. Buy at < ~ $1.20
b. Sell at >~ $2.10
c. Catalysts:
1. Q4 2016 ArQule Inc Earnings Release (Estimated)
-; 20170227; 20170227; https://www.google.com/finance?q=ARQL
2. Phase 3 – Tivantinib (ARQ 197) METIV-HCC trial – Previously treated Inoperable Hepatocellular Carcinoma cancer – Phase 3; 20170331; 20170331; http://investors.arqule.com/releasedetail.cfm?ReleaseID=997914

8) AVIR – Aviragen Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $1.14
b. Sell at >~ $2.00
c. Catalysts:
1. Q2 2017 Aviragen Therapeutics Inc Earnings Release (Estimated)
-; 20170203; 20170203; https://www.google.com/finance?q=AVIR
2. Phase 2b top-line data due early February 2017. – Vapendavir – SPIRITUS trial – Human rhinovirus ( – Phase 2b; 20170214; 20170214; http://investors.aviragentherapeutics.com/releasedetail.cfm?ReleaseID=997545

9) NVLS – Nivalis Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $2.00
b. Sell at >~ $3.00
c. Catalysts:
1. N91115 Cystic Fibrosis – one copy of the F508del mutation and a second mutation that results in a gating defect in the CFTR protein Phase 2
Phase 2 data due 1Q 2017.; 20170101; 20170330; http://biopharmcatalyst.com/companies/company-pipeline-database#sort=company
2. Q4 2016 Nivalis Therapeutics Inc Earnings Release (Estimated); 20170227; 20170227; https://www.google.com/finance?q=NVLS

10) VSTM – Verastem Inc – Trading Below Cash
a. Buy at < ~ $1.07
b. Sell at >~ $1.50
c. Catalysts:
1. Phase 3 data due 1H 2017. – Duvelisib – DUO – Cancer – relapsed/refractory chronic lymphocytic leukemia ( – Phase 3; 20170101; 20170630; http://phoenix.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-newsArticle&ID=2218385
2. Q4 2016 Verastem Inc Earnings Release (Estimated); 20170301; 20170301; https://www.google.com/finance?q=VSTM

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 01/09/2017 - 01/13/2017, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 01/03/2017 – 01/06/2017:

1) ROKA – Roka Bioscience Inc – Trading Below Cash
a. Buy at < ~ $3.66
b. Sell at >~ $14.40
c. Catalysts:
1. Q4 2016 Roka Bioscience Inc Earnings Release (Estimated)
-; 20170302; 20170302; https://www.google.com/finance?q=ROKA

2) RLJE – RLJ Entertainment Inc
a. Buy at < ~ $1.28
b. Sell at >~ $2.80

3) PDLI – PDL BioPharma Inc
a. Buy at < ~ $1.93
b. Sell at >~ $3.90
c. Catalysts:
1. PDL BioPharma to Present at the 2016 BIO CEO & Investor Conference; 20160209; ;
2. Q4 2016 PDL BioPharma Inc Earnings Release (Estimated)
-; 20170220; 20170220; https://www.google.com/finance?q=PDLI

4) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.17
b. Sell at >~ $2.45
c. Catalysts:
1. Q4 2016 Top Image Systems Ltd Earnings Release (Estimated)
-; 20170306; 20170306; https://www.google.com/finance?q=TISA

5) AVIR – Aviragen Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $1.14
b. Sell at >~ $2.00
c. Catalysts:
1. Q2 2017 Aviragen Therapeutics Inc Earnings Release (Estimated)
-; 20170203; 20170203; https://www.google.com/finance?q=AVIR
2. Phase 2b top-line data due early February 2017. – Vapendavir – SPIRITUS trial – Human rhinovirus ( – Phase 2b; 20170214; 20170214; http://investors.aviragentherapeutics.com/releasedetail.cfm?ReleaseID=997545

6) NVLS – Nivalis Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $2.00
b. Sell at >~ $3.00
c. Catalysts:
1. N91115 Cystic Fibrosis – one copy of the F508del mutation and a second mutation that results in a gating defect in the CFTR protein Phase 2
Phase 2 data due 1Q 2017.; 20170101; 20170330; http://biopharmcatalyst.com/companies/company-pipeline-database#sort=company
2. Q4 2016 Nivalis Therapeutics Inc Earnings Release (Estimated); 20170227; 20170227; https://www.google.com/finance?q=NVLS

7) VSTM – Verastem Inc – Trading Below Cash
a. Buy at < ~ $1.07
b. Sell at >~ $1.50
c. Catalysts:
1. Q4 2016 Verastem Inc Earnings Release (Estimated); 20170301; 20170301; https://www.google.com/finance?q=VSTM
2. Phase 3 data due 1H 2017. – Duvelisib – DUO – Cancer – relapsed/refractory chronic lymphocytic leukemia ( – Phase 3; 20170630; 20170630; http://phoenix.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-newsArticle&ID=2218385

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 01/03/2017 - 01/06/2017, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 11/28/2016 – 12/02/2016:

1) ROKA – Roka Bioscience Inc – Trading Below Cash
a. Buy at < ~ $3.66
b. Sell at >~ $14.40

2) IFON – InfoSonics Corporation – Trading Below Cash
a. Buy at < ~ $0.45
b. Sell at >~ $1.33

3) TENX – Tenax Therapeutics Inc
a. Buy at < ~ $1.30
b. Sell at >~ $2.80
c. Catalysts:
1. topline data from Phase 3 LEVO-CTS trial in Jan’17; 20170101; 20170131; https://twitter.com/BioStocks/status/796670020432621568

4) ABIO – Arca Biopharma Inc – Trading Below Cash
a. Buy at < ~ $2.15
b. Sell at >~ $4.20
c. Catalysts:
1. Phase 2b interim analysis of Gencaro – GENETIC-AF trial for Chronic Heart Failure due 2Q 2017; 20170401; 20170630; http://www.arcabiopharma.com/arca-biopharma-announces-first-quarter-2016-financial-results-and-provides-business-update/

5) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.39
b. Sell at >~ $2.45

6) AVIR – Aviragen Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $1.15
b. Sell at >~ $2.00
c. Catalysts:
1. Phase 3 data of TNX-102 SL for Fibromyalgia due 3Q 2016; 20161001; 20161231; http://investors.aviragentherapeutics.com/releasedetail.cfm?ReleaseID=969525
2. Q2 2017 Aviragen Therapeutics Inc Earnings Release (Estimated)
-; 20170203; 20170203; https://www.google.com/finance?q=AVIR

7) VJET – Voxeljet AG (ADR)
a. Buy at < ~ $3.50
b. Sell at >~ $4.75

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 11/28/2016 - 12/02/2016, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 11/21/2016 – 11/25/2016:

1) ROKA – Roka Bioscience Inc – Trading Below Cash
a. Buy at < ~ $3.66
b. Sell at >~ $14.40

2) IFON – InfoSonics Corporation – Trading Below Cash
a. Buy at < ~ $0.45
b. Sell at >~ $1.33

3) TENX – Tenax Therapeutics Inc
a. Buy at < ~ $1.30
b. Sell at >~ $2.80
c. Catalysts:
1. topline data from Phase 3 LEVO-CTS trial in Jan’17; 20170101; 20170131; https://twitter.com/BioStocks/status/796670020432621568

4) ABIO – Arca Biopharma Inc – Trading Below Cash
a. Buy at < ~ $2.15
b. Sell at >~ $4.20
c. Catalysts:
1. Phase 2b interim analysis of Gencaro – GENETIC-AF trial for Chronic Heart Failure due 2Q 2017; 20170401; 20170630; http://www.arcabiopharma.com/arca-biopharma-announces-first-quarter-2016-financial-results-and-provides-business-update/

5) AVIR – Aviragen Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $1.15
b. Sell at >~ $2.00
c. Catalysts:
1. Phase 3 data of TNX-102 SL for Fibromyalgia due 3Q 2016; 20161001; 20161231; http://investors.aviragentherapeutics.com/releasedetail.cfm?ReleaseID=969525
2. Q2 2017 Aviragen Therapeutics Inc Earnings Release (Estimated)
-; 20170203; 20170203; https://www.google.com/finance?q=AVIR

6) BDSI – BioDelivery Sciences International, Inc.
a. Buy at < ~ $1.75
b. Sell at >~ $2.95

7) VJET – Voxeljet AG (ADR)
a. Buy at < ~ $3.50
b. Sell at >~ $4.75

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 11/21/2016 - 11/25/2016, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 11/14/2016 – 11/18/2016:

1) ROKA – Roka Bioscience Inc – Trading Below Cash
a. Buy at < ~ $3.66
b. Sell at >~ $14.40

2) IFON – InfoSonics Corporation – Trading Below Cash
a. Buy at < ~ $0.45
b. Sell at >~ $1.33

3) ABIO – Arca Biopharma Inc – Trading Below Cash
a. Buy at < ~ $2.15
b. Sell at >~ $4.20
c. Catalysts:
1. Phase 2b interim analysis of Gencaro – GENETIC-AF trial for Chronic Heart Failure due 2Q 2017; 20170401; 20170630; http://www.arcabiopharma.com/arca-biopharma-announces-first-quarter-2016-financial-results-and-provides-business-update/

4) VJET – Voxeljet AG (ADR)
a. Buy at < ~ $3.50
b. Sell at >~ $4.75

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 11/14/2016 - 11/18/2016, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 08/15/2016 – 08/19/2016:

1) LPTN – Lpath Inc. – Trading Below Cash
a. Buy at < ~ $1.68
b. Sell at >~ $5.00
c. Catalysts:
1. P1 data in April. Maybe strategic alternative; 20160401; ;
2. hired an advisor to seek strategic alternatives including BO; 20160613; 20161231; http://stocktwits.com/message/60027010#60027139

2) ANY – Sphere 3D Corp.
a. Buy at < ~ $0.68
b. Sell at >~ $1.80

3) QLTI – QLT Inc. – Trading Below Cash
a. Buy at < ~ $1.24
b. Sell at >~ $1.75
c. Catalysts:
1. Closing of merger with AEGR; 20160701; 20160930;

4) QUIK – QuickLogic Corporation
a. Buy at < ~ $0.90
b. Sell at >~ $1.73

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 08/15/2016 - 08/19/2016, and Why?

[Michael DeVries]

This robot-powered burger joint could put fast food workers out of a job => http://www.techinsider.io/momentum-machines-is-hiring-2016-6

How soon do you predict that all of the McDonald’s, Burger Kings, etc. will be automated?

What do you predict will be the impact of the automation of fast food restaurants on jobs for those who currently work there, e.g. teenagers, etc.?

Would you prefer a hamburger made to order by a robot vs. by a person?

Let’s discuss all of these topics here, ok?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 07/11/2016 – 07/15/2016:

1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.57
b. Sell at >~ $1.85

2) LPTN – Lpath Inc. – Trading Below Cash
a. Buy at < ~ $1.71
b. Sell at >~ $5.00
c. Catalysts:
1. P1 data in April. Maybe strategic alternative; 20160401; ;

3) ANY – Sphere 3D Corp.
a. Buy at < ~ $0.68
b. Sell at >~ $1.80

4) SCYX – SCYNEXIS, Inc. – Trading Below Cash
a. Buy at < ~ $2.08
b. Sell at >~ $4.65
c. Catalysts:
1. SCY-078 P2 oral invasive candidiasis top line June and P2 VVC top line July; 20160601; 20160731;
2. Phase 2 topline data of SCY-078 for Invasive Candida infections due July 2016; 20160701; 20160731; http://www.sec.gov/Archives/edgar/data/1178253/000162828016015866/scyx-20160331x10q.htm

5) WSTL – Westell Technologies, Inc.
a. Buy at < ~ $0.66
b. Sell at >~ $1.45

6) OESX – Orion Energy Systems, Inc – Trading Below Cash
a. Buy at < ~ $1.09
b. Sell at >~ $1.55

7) QLTI – QLT Inc. – Trading Below Cash
a. Buy at < ~ $1.24
b. Sell at >~ $1.75
c. Catalysts:
1. Closing of merger with AEGR; 20160701; 20160930;

8) DHT – DHT Holdings, Inc.
a. Buy at < ~ $4.56
b. Sell at >~ $6.40

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 07/11/2016 - 07/15/2016, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 07/05/2016 – 07/08/2016:

1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.57
b. Sell at >~ $1.85

2) ANY – Sphere 3D Corp.
a. Buy at < ~ $0.68
b. Sell at >~ $1.80

3) SCYX – SCYNEXIS, Inc. – Trading Below Cash
a. Buy at < ~ $2.08
b. Sell at >~ $4.65
c. Catalysts:
1. SCY-078 P2 oral invasive candidiasis top line June and P2 VVC top line July; 20160601; 20160731;
2. Phase 2 topline data of SCY-078 for Invasive Candida infections due July 2016; 20160701; 20160731; http://www.sec.gov/Archives/edgar/data/1178253/000162828016015866/scyx-20160331x10q.htm

4) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00

5) WSTL – Westell Technologies, Inc.
a. Buy at < ~ $0.66
b. Sell at >~ $1.45

6) OCRX – Ocera Therapeutics, Inc.
a. Buy at < ~ $1.76
b. Sell at >~ $3.75
c. Catalysts:
1. Phase 2b trial of OCR-002 for Hepatic encephalopathy to complete enrolment 4Q 2016. Data due shortly after.; 20160901; 20170331; http://ir.ocerainc.com/releasedetail.cfm?ReleaseID=958709

7) DGLY – Digital Ally Inc.
a. Buy at < ~ $3.51
b. Sell at >~ $6.50

8) TCON – TRACON Pharmaceuticals, Inc.
a. Buy at < ~ $4.26
b. Sell at >~ $7.75
c. Catalysts:
1. Phase 2 data of TRC105 for Renal Cell Carcinoma due late 2016; 20160901; 20161231; http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2167620
2. Phase 2 data of TRC105 and Avastin for Glioblastoma due by the end of 2016; 20160901; 20161231; ttp://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2167620
3. Phase 2 data of TRC105 and Nexavar for Hepatocellular carcinoma due 2017; 20170101; 20171231; http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2169453

9) OESX – Orion Energy Systems, Inc – Trading Below Cash
a. Buy at < ~ $1.09
b. Sell at >~ $1.55

10) QLTI – QLT Inc. – Trading Below Cash
a. Buy at < ~ $1.24
b. Sell at >~ $1.75
c. Catalysts:
1. Closing of merger with AEGR; 20160701; 20160930;

11) DHT – DHT Holdings, Inc.
a. Buy at < ~ $4.95
b. Sell at >~ $6.40

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 07/05/2016 - 07/08/2016, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 06/27/2016 – 07/01/2016:

1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.57
b. Sell at >~ $1.85

2) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.10

3) ANY – Sphere 3D Corp.
a. Buy at < ~ $0.68
b. Sell at >~ $1.80

4) SCYX – SCYNEXIS, Inc. – Trading Below Cash
a. Buy at < ~ $2.12
b. Sell at >~ $4.65
c. Catalysts:
1. SCY-078 P2 oral invasive candidiasis top line June and P2 VVC top line July; 20160601; 20160731;
2. Phase 2 topline data of SCY-078 for Invasive Candida infections due July 2016; 20160701; 20160731; http://www.sec.gov/Archives/edgar/data/1178253/000162828016015866/scyx-20160331x10q.htm

5) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00

6) WSTL – Westell Technologies, Inc.
a. Buy at < ~ $0.70
b. Sell at >~ $1.45

7) OCRX – Ocera Therapeutics, Inc.
a. Buy at < ~ $1.92
b. Sell at >~ $3.75
c. Catalysts:
1. Phase 2b trial of OCR-002 for Hepatic encephalopathy to complete enrolment 4Q 2016. Data due shortly after.; 20160901; 20170331; http://ir.ocerainc.com/releasedetail.cfm?ReleaseID=958709

8) DGLY – Digital Ally Inc.
a. Buy at < ~ $3.51
b. Sell at >~ $6.50

9) TCON – TRACON Pharmaceuticals, Inc.
a. Buy at < ~ $4.90
b. Sell at >~ $7.75
c. Catalysts:
1. Phase 2 data of TRC105 for Renal Cell Carcinoma due late 2016; 20160901; 20161231; http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2167620
2. Phase 2 data of TRC105 and Avastin for Glioblastoma due by the end of 2016; 20160901; 20161231; ttp://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2167620
3. Phase 2 data of TRC105 and Nexavar for Hepatocellular carcinoma due 2017; 20170101; 20171231; http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2169453

10) OESX – Orion Energy Systems, Inc – Trading Below Cash
a. Buy at < ~ $1.12
b. Sell at >~ $1.55

11) QLTI – QLT Inc. – Trading Below Cash
a. Buy at < ~ $1.33
b. Sell at >~ $1.75
c. Catalysts:
1. Closing of merger with AEGR; 20160701; 20160930;

12) DHT – DHT Holdings, Inc.
a. Buy at < ~ $4.95
b. Sell at >~ $6.40

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 06/27/2016 - 07/01/2016, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 06/20/2016 – 06/24/2016:

1) SGNL – Signal Genetics, Inc.
a. Buy at < ~ $0.41
b. Sell at >~ $1.10

2) BIOC – Biocept, Inc.
a. Buy at < ~ $0.57
b. Sell at >~ $1.85

3) WSTL – Westell Technologies, Inc.
a. Buy at < ~ $0.73
b. Sell at >~ $1.45

4) ANY – Sphere 3D Corp.
a. Buy at < ~ $0.92
b. Sell at >~ $1.80

5) SCYX – SCYNEXIS, Inc.
a. Buy at < ~ $2.45
b. Sell at >~ $4.65
c. Catalysts:
1. SCY-078 P2 oral invasive candidiasis top line June and P2 VVC top line July; 20160601; 20160731;
2. Phase 2 topline data of SCY-078 for Invasive Candida infections due July 2016; 20160701; 20160731; http://www.sec.gov/Archives/edgar/data/1178253/000162828016015866/scyx-20160331x10q.htm

6) OCRX – Ocera Therapeutics, Inc.
a. Buy at < ~ $2.00
b. Sell at >~ $3.75
c. Catalysts:
1. Phase 2b trial of OCR-002 for Hepatic encephalopathy to complete enrolment 4Q 2016. Data due shortly after.; 20160901; 20170331; http://ir.ocerainc.com/releasedetail.cfm?ReleaseID=958709

7) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00

8) DGLY – Digital Ally Inc.
a. Buy at < ~ $3.51
b. Sell at >~ $6.50

9) TCON – TRACON Pharmaceuticals, Inc.
a. Buy at < ~ $5.00
b. Sell at >~ $7.75
c. Catalysts:
1. Phase 2 data of TRC105 for Renal Cell Carcinoma due late 2016; 20160901; 20161231; http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2167620
2. Phase 2 data of TRC105 and Avastin for Glioblastoma due by the end of 2016; 20160901; 20161231; ttp://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2167620
3. Phase 2 data of TRC105 and Nexavar for Hepatocellular carcinoma due 2017; 20170101; 20171231; http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2169453

10) OESX – Orion Energy Systems, Inc
a. Buy at < ~ $1.17
b. Sell at >~ $1.55

11) DHT – DHT Holdings, Inc.
a. Buy at < ~ $4.95
b. Sell at >~ $6.40

12) QLTI – QLT Inc. – Trading Below Cash
a. Buy at < ~ $1.38
b. Sell at >~ $1.75
c. Catalysts:
1. Closing of merger with AEGR; 20160701; 20160930;

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 06/20/2016 - 06/24/2016, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 06/13/2016 – 06/17/2016:

1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.57
b. Sell at >~ $1.85
c. Catalysts:

2) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.10

3) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:

4) WSTL – Westell Technologies, Inc.
a. Buy at < ~ $0.74
b. Sell at >~ $1.45
c. Catalysts:

5) DGLY – Digital Ally Inc.
a. Buy at < ~ $3.51
b. Sell at >~ $6.50
c. Catalysts:

6) ANY – Sphere 3D Corp.
a. Buy at < ~ $1.00
b. Sell at >~ $1.80
c. Catalysts:

7) PLX – Protalix BioTherapeutics, Inc.
a. Buy at < ~ $0.75
b. Sell at >~ $1.05
c. Catalysts:
1. Phase 2 data of PLX-PAD (stem cells) for Intermittent claudication, or IC are due 2017; 20170101; 20171231; http://www.pluristem.com/wp-content/uploads/2016/05/IC-trial_final.pdf

8) ABIO – ARCA biopharma, Inc. – Trading Below Cash
a. Buy at < ~ $3.05
b. Sell at >~ $4.20
c. Catalysts:
1. Phase 2b interim analysis of Gencaro – GENETIC-AF trial for Chronic Heart Failure due 2Q 2017; 20170401; 20170630; http://www.arcabiopharma.com/arca-biopharma-announces-first-quarter-2016-financial-results-and-provides-business-update/

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 06/13/2016 - 06/17/2016, and Why?

[Michael DeVries]

If robots are the future of work, where do humans fit in? => http://www.theguardian.com/commentisfree/2016/may/24/robots-future-work-humans-jobs-leisure?CMP=share_btn_tw

What do you think about all of this?
Where do you predict that humans will fit in when robots can do much of the work that people currently do?

Let’s discuss it all here, ok?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 05/30/2016 – 06/03/2016:

1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.60
b. Sell at >~ $1.85
c. Catalysts:

2) IFON – Infosonics Corp.
a. Buy at < ~ $0.42
b. Sell at >~ $1.33
c. Catalysts:

3) XOMA – XOMA Corporation
a. Buy at < ~ $0.65
b. Sell at >~ $2.00
c. Catalysts:
1. XOMA 358 Phase 2 test results June- July; 20160601; 20160731;
2. Phase2/proof-of-concept data from XOMA 358 and potentially Phase 3 from gevokizuamb; 2016; ;

4) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.10
c. Catalysts:
1. Signal Genetics to Present at the LD Micro Invitational June 8th, at 4:00pm EST; 20160608; 20160608; http://finance.yahoo.com/news/signal-genetics-present-ld-micro-123000882.html

5) DCTH – Delcath Systems, Inc. – Trading Below Cash
a. Buy at < ~ $0.25
b. Sell at >~ $0.65

6) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.39
b. Sell at >~ $3.59
c. Catalysts:

7) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:

8) ANY – Sphere 3D Corp.
a. Buy at < ~ $1.02
b. Sell at >~ $1.80
c. Catalysts:

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 05/30/2016 - 06/03/2016, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 05/23/2018 – 05/27/2018:

1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.63
b. Sell at >~ $3.92
c. Catalysts:

2) IFON – Infosonics Corp.
a. Buy at < ~ $0.42
b. Sell at >~ $1.33
c. Catalysts:

3) XOMA – XOMA Corporation
a. Buy at < ~ $0.65
b. Sell at >~ $2.00
c. Catalysts:
1. XOMA 358 Phase 2 test results June- July; 20160601; 20160731;
2. Phase2/proof-of-concept data from XOMA 358 and potentially Phase 3 from gevokizuamb; 2016; ;

4) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.10
c. Catalysts:

5) DCTH – Delcath Systems, Inc. – Trading Below Cash
a. Buy at < ~ $0.25
b. Sell at >~ $0.65

6) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.39
b. Sell at >~ $3.59
c. Catalysts:

7) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:

8) ANY – Sphere 3D Corp.
a. Buy at < ~ $1.02
b. Sell at >~ $1.80
c. Catalysts:

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 05/23/2018 - 05/27/2018, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 05/16/2018 – 05/20/2018:

1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.63
b. Sell at >~ $3.92
c. Catalysts:

2) BDSI – BioDelivery Sciences International, Inc.
a. Buy at < ~ $1.95
b. Sell at >~ $6.20
c. Catalysts:

3) IFON – Infosonics Corp.
a. Buy at < ~ $0.42
b. Sell at >~ $1.33
c. Catalysts:

4) XOMA – XOMA Corporation
a. Buy at < ~ $0.65
b. Sell at >~ $2.00
c. Catalysts:
1. XOMA 358 Phase 2 test results June- July; 20160601; 20160731;
2. Phase2/proof-of-concept data from XOMA 358 and potentially Phase 3 from gevokizuamb; 2016; ;

5) DCTH – Delcath Systems, Inc. – Trading Below Cash
a. Buy at < ~ $0.25
b. Sell at >~ $0.65

6) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.39
b. Sell at >~ $3.59
c. Catalysts:

7) ANY – Sphere 3D Corp.
a. Buy at < ~ $1.02
b. Sell at >~ $1.80
c. Catalysts:

8) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 05/16/2018 - 05/20/2018, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 04/25/2018 – 04/29/2018:

1) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.10
c. Catalysts:

2) DCTH – Delcath Systems, Inc. – Trading Below Cash
a. Buy at < ~ $0.25
b. Sell at >~ $0.65

3) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.39
b. Sell at >~ $3.59
c. Catalysts:

4) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:

5) NVET – Nexvet Biopharma Public Limited Company – Trading Below Cash
a. Buy at < ~ $2.85
b. Sell at >~ $5.80
c. Catalysts:

6) CALL – magicJack VocalTec Ltd.
a. Buy at < ~ $5.83
b. Sell at >~ $10.74
c. Catalysts:

7) ANY – Sphere 3D Corp.
a. Buy at < ~ $1.02
b. Sell at >~ $1.80
c. Catalysts:

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 04/25/2018 - 04/29/2018, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 04/18/2018 – 04/22/2018:

1) SGYP – Synergy Pharmaceuticals, Inc.
a. Buy at < ~ $2.50
b. Sell at >~ $9.76
c. Catalysts:
1. results from the second phase 3 IBS-C trial in 2H 2016; 20160601; 20161231; http://finance.yahoo.com/news/synergy-pharmaceuticals-files-drug-application-165700407.html
2. The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) (IBS-C) Estimated Study Completion Date; 20160701; 20160731; https://clinicaltrials.gov/ct2/show/NCT02387359?term=IBS-C&rank=1

2) XOMA – XOMA Corporation
a. Buy at < ~ $0.69
b. Sell at >~ $2.00
c. Catalysts:
1. Phase2/proof-of-concept data from XOMA 358 and potentially Phase 3 from gevokizuamb; 2016; ;

3) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.10
c. Catalysts:

4) DCTH – Delcath Systems, Inc. – Trading Below Cash
a. Buy at < ~ $0.25
b. Sell at >~ $0.65

5) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.39
b. Sell at >~ $3.59
c. Catalysts:

6) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:

7) FSNN – Fusion Telecommunications International, Inc.
a. Buy at < ~ $1.68
b. Sell at >~ $3.80
c. Catalysts:

8) NVET – Nexvet Biopharma Public Limited Company – Trading Below Cash
a. Buy at < ~ $2.85
b. Sell at >~ $5.80
c. Catalysts:

9) CALL – magicJack VocalTec Ltd.
a. Buy at < ~ $5.88
b. Sell at >~ $10.74
c. Catalysts:

10) ANY – Sphere 3D Corp.
a. Buy at < ~ $1.02
b. Sell at >~ $1.80
c. Catalysts:

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 04/18/2018 - 04/22/2018, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 04/11/2018 – 04/15/2018:

1) RBCN – Rubicon Technology, Inc. – Trading Below Cash
a. Buy at < ~ $0.65
b. Sell at >~ $4.76
c. Catalysts:

2) SGYP – Synergy Pharmaceuticals, Inc.
a. Buy at < ~ $2.50
b. Sell at >~ $9.76
c. Catalysts:
1. results from the second phase 3 IBS-C trial in 2H 2016; 20160601; 20161231; http://finance.yahoo.com/news/synergy-pharmaceuticals-files-drug-application-165700407.html
2. The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) (IBS-C) Estimated Study Completion Date; 20160701; 20160731; https://clinicaltrials.gov/ct2/show/NCT02387359?term=IBS-C&rank=1

3) RPRX – Repros Therapeutics Inc. – Trading Below Cash
a. Buy at < ~ $0.80
b. Sell at >~ $2.70
c. Catalysts:

4) XOMA – XOMA Corporation
a. Buy at < ~ $0.69
b. Sell at >~ $2.00
c. Catalysts:
1. Phase2/proof-of-concept data from XOMA 358 and potentially Phase 3 from gevokizuamb; 2016; ;

5) FSNN – Fusion Telecommunications International, Inc.
a. Buy at < ~ $1.70
b. Sell at >~ $4.80
c. Catalysts:

6) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.10
c. Catalysts:

7) DCTH – Delcath Systems, Inc. – Trading Below Cash
a. Buy at < ~ $0.25
b. Sell at >~ $0.65

8) CRIS – Curis, Inc.
a. Buy at < ~ $1.25
b. Sell at >~ $3.10
c. Catalysts:
1. Phase 1 update from CUDC-907, CA-170 and potential additional programs; 2016; ; https://finance.yahoo.com/news/curis-present-bio-ceo-investor-210500148.html

9) PERI – Perion Network Ltd.
a. Buy at < ~ $1.68
b. Sell at >~ $3.90
c. Catalysts:

10) MSTX – Mast Therapeutics, Inc.
a. Buy at < ~ $0.22
b. Sell at >~ $0.50
c. Catalysts:
1. MAST THERAPEUTICS TO PRESENT AT THE 10TH ANNUAL SICKLE CELL SYMPOSIUM\n\nMAST THERAPEUTICS COMPLETES PATIENT… on Sunday, April 17 • 6:30pm – 7:30pm; 20160417; 20160417; http://10thsicklecelldiseaseresear2016.sched.org/event/a101f92d0c5a30e5b8908c2a147713c8#.Vtn3TURIKKo.facebook

11) LPTN – Lpath Inc. – Trading Below Cash
a. Buy at < ~ $0.14
b. Sell at >~ $0.31

12) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:

13) CALL – magicJack VocalTec Ltd.
a. Buy at < ~ $5.88
b. Sell at >~ $10.74
c. Catalysts:

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 04/11/2018 - 04/15/2018, and Why?

[Author]

Posts